Aarsland, D., Larsen, J. P., Cummings, J. L., and Laake, K. 1999. Prevalence and clinical correlates of psychotic symptoms in Parkinson Disease. A community-based study. Arch Neurol 56: 595–601.Google Scholar

Abrams, R. 2002. Electroconvulsive therapy, 4th edn. New York: Oxford University Press.

Abrams, R. and Taylor, M. A. 1983. The importance of mood-incongruent psychotic symptoms in melancholia. J Affect Disord 5: 179–81.Google Scholar

Alexopoulos, G. S., Meyers, B. S., Young, R. C., et al. 1993. The course of geriatric depression with “reversible dementia”: A controlled study. Am J Psychiatry 150: 1693–9.Google Scholar

American Psychiatric Association (APA) 1994. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: APA, pp. 348, 384–6.

Amsterdam, J. D. and Shults, J. 2005. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: A double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 20: 257–64.Google Scholar

Andreassen, O. A., Ferrante, R. J., Aamo, T. O., et al. 2003. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122: 717–25.Google Scholar

Angst, F., Stassen, H. H., Clayton, P. J., and Angst, J. 2002. Mortality of patients with mood disorders: Follow-up over 34–38 years. J Affect Disord 68: 167–81.Google Scholar

Anton, R. F. Jr. and Burch, E. A. Jr. 1990. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 147: 1203–8.Google Scholar

Anton, R. F. Jr. and Burch, E. A. Jr. 1993. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord 28: 125–31.Google Scholar

Aronson, T. A., Shukla, S., and Hoff, A. 1987. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251–9.Google Scholar

Aronson, T. A., Shukla, S., Hoff, A., and Cook, B. 1988. Proposed delusional depression subtypes: Preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69–74Google Scholar

Arroll, B., Macgillivray, S., Ogston, S., et al. 2005. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis. Ann Family Med 3: 449–56.Google Scholar

Associated Press. 2006. Woman not guilty in retrial in the deaths of her 5 children. New York Times, July 27, p. A18.

Avery, D. and Lubrano, A. 1979. Depression treated with imipramine and ECT: The DeCarolis study reconsidered. Am J Psychiatry 136: 559–62.Google Scholar

Avery, D. and Winokur, G. 1976. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029–37.Google Scholar

Bakish, D. 2001. New standard of depression treatment: Remission and full recovery. J Clin Psychiatry 62(Suppl 26): 5–9.Google Scholar

Banken, R. 2002. The use of electroconvulsive therapy in Quebec. Agence d'valuation des technologies et des modes d'intervention en sant (AETMIS). Montreal: AETMIS.

Bassett, S. S. 2005. Cognitive impairment in Parkinson's Disease. Prim Psychiatry 12: 50–55.Google Scholar

Bayley, J. 1881. Case of recurrent melancholia. Lancet 2: 1041–2.Google Scholar

Beck, A. T. 1967. Depression: Clinical, experimental, and theoretical aspects. New York: Harper & Row.

Belanoff, J. K., Rothschild, A. J., Cassidy, F., et al. 2002. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386–92.Google Scholar

Bellini, L., Gatti, F., Gasperini, M., and Smeraldi, E. 1992. A comparison between delusional and non-delusional depressives. J Affect Disord 25: 129–38.Google Scholar

Benziger, B. F. 1969. The prison of my mind. New York: Walker.

Bergemann, N., Frick, A., Parzer, P., and Kopitz, J. 2004. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. Pharmacopsychiatry 37: 63–8.Google Scholar

Birkenhager, T. K. and Moleman, P. 1999. Two new antidepressants: Mirtazapine and venlafaxine. Ned Tijdscr Geneeskd 143: 934–7.Google Scholar

Birkenhager, T. K., Pluijms, E. M., and Lucius, S. A. 2003. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord 74: 191–5.Google Scholar

Black, D. W. and Winokur, G. 1989. Psychotic and nonpsychotic depression: Comparison of response to ECT. J Clin Psychiatry 50: 186.Google Scholar

Bonomo, V. and Fogliani, A. M. 2000. Citalopram and haloperidol for psychotic depression. Am J Psychiatry 157: 1706–7.Google Scholar

Bowers, M. B. and Swigar, M. E. 1988. Psychotic patients who become worse on neuroleptics. J Clin Psychopharmacol 8: 417–21.Google Scholar

Bremner, J. D., Vythinlingam, M., Ng, C. K., et al. 2003. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 289: 3125–34.Google Scholar

Breslau, N. and Meltzer, H. Y. 1988. Validity of subtyping psychotic depression: Examination of phenomenology and demographic characteristics. Am J Psychiatry 145: 35–40.Google Scholar

Brockington, I. F., Roper, A., Copas, J., et al. 1991. Schizophrenia, bipolar disorder and depression. A discriminant analysis, using “lifetime” psychopathology ratings. Br J Psychiatry 159: 485–94.Google Scholar

Brown, G. W., Ni Bhrolchain, M., and Harris, T. O. 1979. Psychotic and neurotic depression. Part 3. Aetiological and background factors. J Affect Disord 1: 195–211.Google Scholar

Brown, R. P., Frances, A., Kocsis, J. H., and Mann, J. J. 1982. Psychotic vs. nonpsychotic depression: Comparison of treatment response. J Nerv Ment Dis 170: 635–7Google Scholar

Brown, T. A., Campbell, L. A., Lehman, C. L., et al. 2001. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 110: 585–99.Google Scholar

Brujin, J. A., Moleman, P., Mulder, P. G., et al. 1996. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacol (Berlin) 237: 231–7.Google Scholar

Burch, E. A. and Goldschmidt, T. J. 1983. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. South Med J 76: 991–5.Google Scholar

Cade, J. F. J. 1949. Lithium salts in the treatment of psychotic excitement. Med J Aust 2: 349–52.Google Scholar

Calabrese, J. R., Keck, P. B., MacFadden, W., et al. 2005. A randomized double-blind placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162: 1351–60.Google Scholar

Carpenter, W. T. and Buchanan, R. W. 1994. Schizophrenia. N Engl J Med 330: 681–90.Google Scholar

Carroll, B. J. 1981. Review of Harold I. Kaplan, et al. (eds) Comprehensive textbook of psychiatry, 3rd edn. Am J Psychiatry 138: 705–7.

Carroll, B. J. 1982. The dexamethasone suppression test for melancholia. Br J Psychiatry 140: 292–304.Google Scholar

Carroll, B. J. 1983. Neurobiologic dimensions of depression and mania. In Jules Angst (ed.) The origins of depression: Current concepts and approaches. Berlin: Springer.

Carroll, B. J., Curtis, G. C., and Mendels, J. 1976. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6: 235–44.Google Scholar

Carroll, B. T., Thomas, C., Jayanti, K., et al. 2005. Treating persistent catatonia when benzodiazepines fail. Curr Psychiatry 4: 56–64.Google Scholar

Casey, D. A. 1987. Electroconvulsive therapy in the neuroleptic malignant syndrome. Convuls Ther 3: 278–83.Google Scholar

Cerletti, U. 1940. L'Elettroshock. Rivista Sperimentale di Freniatria 64: 209–310.Google Scholar

Chan, C. H., Janicak, P. G., Davis, J. M., et al. 1987. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 48: 197–200.Google Scholar

Chelminski, I., Zimmerman, M., and Mattia, J. I. 2000. Diagnosing melancholia. J Clin Psychiatry 61: 874–5.Google Scholar

Chouinard, G. and Steinberg, S. 1984. New clinical concepts on neuroleptic-induced supersensitivity disorders: Tardive dyskinesia and supersensitivity psychosis. In Stancer, H. C., Garfinkel, P. E., and Rakoff, V. M. (eds) Guidelines for the use of psychotropic drugs. New York: Spectrum, pp. 205–27.

Corcept Therapeutics, Inc. 2006. Corcept Therapeutics announces negative results from the first of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression. PR Newswire, August 25, accessed September 13, 2006 at http://biz.yahoo.com/prnews/060825/laf018.html?.v=61

Cotard, J. 1880. Du délire des négations. Archives de neurologie 4: 152–70.Google Scholar

Coryell, W. and Tsuang, M. T. 1982. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry 39: 1181–4.Google Scholar

Coryell, W., Pfohl, B., and Zimmerman, M. 1984. The clinical and neuroendocrine features of pscyhotic depression. J Nerv Ment Dis 172: 521–8.Google Scholar

Coryell, W., Zimmerman, M., and Pfohl, B. 1986. Outcome at discharge and six months in major depression. The significance of psychotic features. J Nerv Ment Dis 174: 92–6Google Scholar

Cullen, M., Mitchell, P., Brodaty, H., et al. 1991. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 52: 472–6.Google Scholar

Davidson, J., McLeod, M., Law-Yone, B., and Linnoila, M. 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–42.Google Scholar

DeBattista, C., Belanoff, J., Glass, S., et al. 2006. Mifeprisone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 60: 1343–9.Google Scholar

Montigny, C., Grunberg, F., Mayer, A., et al. 1981. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–6.Google Scholar

DelBello, M. P., Carlson, G. A., Tohen, M., et al. 2003. Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. J Child Adolesc Psychopharmacol 13: 173–85.Google Scholar

Denber, H. C. B. 1957. Treatment of chlorpromazine-diethazine in depression. Dis Nerv Syst 17: 76–9.Google Scholar

Denno, D. W. 2003. Who is Andrea Yates? A short story about insanity. Duke J Gend Law Policy 10: 1–139.Google Scholar

Dietrich, D. E., Godecke-Koch, T., Richter-Witte, C., and Emrich, H. M. 2004. Lamotrigine in the treatment of confusion psychosis, a case report. Pharmacopsychiatry 37: 88–90.Google Scholar

Donlon, P. T., Biertuemphel, H., and Willenbring, M. 1981. Amoxapine and amitriptyline in the outpatient treatment of endogenous depression. J Clin Psychiatry 42: 11–15.Google Scholar

Downs, J. M., Akiskal, H. G., and Rosenthal, T. L. 1993. Neuroleptic-induced pseudoschizoaffective disorder (abstract 146). Proc Am Psychiatric Assoc Annual Meet, p. 153 (full program on audiotape).Google Scholar

Dubovsky, S. L. and Thomas, M. 1992. Psychotic depression: Advances in conceptualization and treatment. Hosp Comm Psychiatry 43: 1189–98.Google Scholar

Eagles, J. M. 1983. Delusional depressive in-patients, 1892–1982. Br J Psychiatry 143: 558–63.Google Scholar

Erfurth, A., Walden, J., and Grunze, H. 1998. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38: 204–5.Google Scholar

Ernst, K. 1983. Geisteskrankheit ohne institution: eine feldstudie im Kanton Fribourg aus dem jahr 1875. Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie 133: 239–62.Google Scholar

Evans, D. L. and Nemeroff, C. B. 1987. The clinical use of the Dexamethasone Suppression Test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatr Res 21: 185–94.Google Scholar

Feighner, J. P., Robins, E., Guze, S. B., et al. 1972. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63.Google Scholar

Fenichel, O. 1945. The psychoanalytic theory of neurosis. New York: Norton.

Fink, M. 1979. A theory of convulsive therapy (chapter 14). In M. Fink (ed.) Convulsive therapy: Theory and practice. New York: Raven Press, p. 173.

Fink, M. and Taylor, M. A. 2003. Catatonia: A clinician's guide to diagnosis and treatment. New York: Cambridge University Press.

Fink, M., Klein, D. F., and Kramer, J. C. 1965. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Psychopharmacologia 7: 27–36.Google Scholar

Finlay-Jones, R. and Parker, G. 1993. A consensus conference on psychotic depression. Aust NZ J Psychiatry 27: 581–9.Google Scholar

Fish, F. 1964. Concluding observations. In E. Beresford Davies (ed.) Depression: Proceedings of the symposium held at Cambridge 22 to 26 September 1959. Cambridge, UK: Cambridge University Press, pp. 349–52.

Flint, A. J. and Rifat, S. L. 1998a. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–8.Google Scholar

Flint, A. J. and Rifat, S. L. 1998b. Two-year outcome of psychotic depression in late life. Am J Psychiatry 155: 178–83.Google Scholar

Flor-Henry, P. 1983. Determinants of psychosis in epilepsy, laterality and forced normalization. Biol Psychiatry 18: 1045–57.Google Scholar

Freud, S. 1946. Trauer und melancholie (1916). In Freud, (ed.) Gesammelte Werke, vol. 10. Frankfurt: M. Fischer, pp. 428–46.

Freyhan, F. A. 1959. Clinical effectiveness of tofranil in the treatment of depressive psychoses. Can Psychiatr Assoc J 4(Suppl): S86–S97.Google Scholar

Freyhan, F. A. 1961. The influence of specific and non-specific factors on the clinical effects of psychotropic drugs. Neuropsychopharmacology 2: 189–203.Google Scholar

Fricchione, G. L., Cassem, N. H., and Hooberman, D. 1983. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 3: 338–42.Google Scholar

Fritsch, J. 1882. Diagnostik und therapie der melancholischen krankheitsformen. Zeitschrift für Diagnostik und Therapie 1: 101–3.Google Scholar

Frueh, B. C., Knapp, R. G., Cusack, K. J., et al. 2005. Patients' reports of traumatic or harmful experience within the psychiatric setting. Psychiatric Serv 56: 1123–33.Google Scholar

Gatti, F., Bellini, L., Gasperini, M., et al. 1996. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 153: 414–6.Google Scholar

Gaupp, R. 1926. Krankheitseinheit und mischpsychosen. Zeitschrift fur die gesamteNeurologie und Psychiatrie 101: 1–15.Google Scholar

Ghaemi, S. N., Lenox, M. S., and Baldessarini, R. J. 2001. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 62: 565–9.Google Scholar

Gillespie, R. D. 1926. Discussion comment. BMJ 2: 878.Google Scholar

Gimsa, U., Schreiber, U., Habel, B., et al. 2006. Matching geometry and stimulation parameters of electrodes for deep brain stimulation experiments – numerical considerations. J Neurosci Meth 150: 212–27.Google Scholar

Glassman, A. H. and Roose, S. P. 1981. Delusional depression: A distinct clinical entity?Arch Gen Psychiatry 38: 424–7.Google Scholar

Glassman, A. H., Kantor, S. J., and Shostak, M. 1975. Depression, delusions, and drug response. Am J Psychiatry 132: 716–19.Google Scholar

Glick, I. D., Murray, S. R., Vasudevan, P., et al. 2001. Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res 35: 187–91.Google Scholar

Goldman, D. 1955. The effect ofchlorpromazine on severe mental and emotional disturbances. In Chlorpromazine and mental health: Proceedings of the symposium held under the auspices of Smith, Kline & French Laboratories, June 6, 1955. Philadelphia: Lea & Febiger, pp. 19–40.

Goodwin, F. K., Prange, A. J., Post, R. M., Muscettola, G., and Lipton, M. A. 1982. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry 139: 34–8.Google Scholar

Goren, J. L. and Levin, G. M. 2000. Mania with bupropion: A dose-related phenomenon?Ann Pharmacother 34: 619–21.Google Scholar

Gournellis, R., Lykouras, L., Fortos, A., et al. 2001. Psychotic (delusional) major depression in late life: A clinical study. Int J Geriatr Psychiatry 16: 1085–91.Google Scholar

Grunhaus, L., Dannon, P. N., Schreiber, S., et al. 2000. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study. Biol Psychiatry 47: 314–24.Google Scholar

Grunze, H., Marcuse, A., Scharer, L. O., et al. 2002. Nefazodone in psychotic unipolar and bipolar depression: A retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol. Neuropsychobiology 46(Suppl 1): 31–5.Google Scholar

Guze, S. B., Woodruff, R. A., Jr, and Clayton, P. J. 1975. The significance of psychotic affective disorders. Arch Gen Psychiatry 32: 1147–50.Google Scholar

Hamilton, M. 1989. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154: 201–6.Google Scholar

Hermann, R. C., Dorwart, R. A., Hoover, C. W., and Brody, J. 1995. Variation in ECT use in the United States. Am J Psychiatry 152: 869–75.Google Scholar

Hill, S. K., Keshavan, M. S., Thase, M. E., and Sweeney, J. A. 2004. Neuropsychological dysfunction in antipsychotic-naïve first-episode unipolar psychotic depression. Am J Psychiatry 161: 996–1003.Google Scholar

Hippius, H. and Jantz, H. 1959. Die heutige behandlung der depressionen. Nervenarzt 30: 466–73.Google Scholar

Hoch, A. and MacCurdy, J. T. 1922 The prognosis of involution melancholia. Arch Neurol Psychiatry 7: 1–37.Google Scholar

Hodgkiss, A. D., Malizia, A. L., Bartlett, J. R., and Bridges, P. K. 1995. Outcome after the psychosurgical operation of stereotactic subcaudate tractotomy, 1979–1991. J Neuropsychiatry Clin Neurosci 7: 230–4.Google Scholar

Hoff, H. 1959. Indications for electro-shock, tofranil and psychotherapy in the treatment of depressions. Can Psychiatr Assoc J 4(Suppl): S55–S68.Google Scholar

Hollister, L. E. and Overall, J. E. 1965. Reflections on the specificity of action of anti-depressants. Psychosomatics 6: 361–5.Google Scholar

Honoré, P., Moller, S. E., and Jorgensen, A. 1982. Lithium + l-tryptophan compared with amitriptyline in endogenous depression. J Affect Disord 4: 79–82.Google Scholar

Hordern, A., Holt, N. F., Burt, C. G., and Gordon, W. F. 1963. Amitriptyline in depressive states: Phenomenology and prognostic considerations. Br J Psychiatry 10: 815–25.Google Scholar

Jager, M., Bottlender, R., Strauss, A., and Moller, H. J. 2005. Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: The prognostic significance of psychotic features. Compr Psychiatry 46: 322–7.Google Scholar

Jain, V. and Swartz, C. M. 2002. Charcoal enhancement of treatment for tricyclic-induced mania. Pharmacopsychiatry 35: 197–9.Google Scholar

Janicak, P. G., Pandey, G. N., Davis, J. M., et al. 1988. Response of psychotic and nonpsychotic depression to phenelzine. Am J Psychiatry 145: 93–5.Google Scholar

Jaspers, K. 1913. Allgemeine psychopathologie. Berlin: Springer.

Jeste, D. V., Heaton, S. C., Paulsen, J. S., et al. 1996. Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. Am J Psychiatry 153: 490–6.Google Scholar

Joffe, R. T., MacQueen, G. M., Marriott, M., et al. 2002. Induction of mania and cycle acceleration in bipolar disorder: Effect of different classes of antidepressant. Acta Psychiatr Scand 105: 427–30.Google Scholar

Johnson, J., Horwath, E., and Weissman, M. M. 1991. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 48: 1075–81.Google Scholar

Joseph, K. S., Blais, L., Ernst, P., and Suissa, S. 1996. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 312(7023): 79–82.Google Scholar

Judd, L. L., Akiskal, H. S., Schettler, P. J., et al. 2002. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59: 530–7.Google Scholar

Judd, L. L., Paulus, M. J., Schettler, P. J., et al. 2000. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?Am J Psychiatry 157: 1501–4.Google Scholar

Kahlbaum, K. 1863. Die Gruppirung der Psychischen Krankheiten und die Eintheilung der Seelenstörungen. Danzig: Kafemann.

Kalinowsky, L. B. 1941. The various forms of shock therapy in mental disorders and their practical importance. NY State J Med 41: 2210–15.Google Scholar

Kantor, S. J. and Glassman, A. H. 1977. Delusional depressions: Natural history and response to treatment. Br J Psychiatry 131: 351–60.Google Scholar

Kellner, C. H., Fink, M., Knapp, R., et al. 2005. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 162: 977–82.Google Scholar

Kendell, R. E., Chalmers, J. C., and Platz, C. 1987. Epidemiology of puerperal psychoses. Br J Psychiatry 150: 662–73.Google Scholar

Kielholz, P. 1954. Über die largactilwirkung bei depressiven zuständen und manien sowie bei der entziehung von morphin- und barbitursüchtigen. Schweizer Archiv für Neurologie und Psychiatrie 73: 291–309.Google Scholar

Kiloh, L. G. and Garside, R. F. 1963. The independence of neurotic depression and endogenous depression. Br J Psychiatry 109: 451–63.Google Scholar

Kiloh, L. G. and Garside, R. F. 1977. Depression: A multivariate study of Sir Aubrey Lewis's data on melancholia. Aust NZ J Psychiatry 11: 149–56.Google Scholar

Kinross-Wright, V. 1955. Chlorpromazine treatment of mental disorders. Am J Psychiatry 111: 907–12.Google Scholar

Kirk, S. A. and Kutchins, H. 1992. The selling of DSM: The rhetoric of science in psychiatry. New York: Aldine.

Kiser, S. 2004. An existential case study of madness: Encounters with divine affliction. J Human Psychol 44: 431–54.Google Scholar

Kivela, S. L. and Pahkala, K. 1989. Delusional depression in the elderly: A community study. Zeitschrift fur Gerontologie 22: 236–41.Google Scholar

Klein, D. and Fink, M. 1962. Behavioral reaction patterns with phenothiazines. Arch Gen Psychiatry 7: 449–59.Google Scholar

Klein, D. F. 1976. Differential diagnosis and treatment of the dysphorias. In Gallant, Donald M. (ed.) Depression: Behavioral, biochemical, diagnostic and treatment concepts. New York: Spectrum, pp. 127–54.

Klerman, G. L. 1974. Unipolar and bipolar depressions. In Jules Angst (ed.) Classification and prediction of outcome of depression. Stuttgart: F. K. Schattauer, pp. 49–74.

Klerman, G. L. and Cole, J. O. 1965. Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17: 101–41.Google Scholar

Kocsis, J. H., Croughan, J. L., Katz, M. M., et al. 1990. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. Am J Psychiatry 147: 621–4.Google Scholar

Kostiukova, E. G. 1989. Comparative features of the preventive action of carbamazepine and lithium carbonate in affective and schizoaffective psychoses. Zhurnal Nevropatologii I Psikhiatrii Imeni S-S-Korsakova 89: 64–71.Google Scholar

Kraepelin, E. 1913. Psychiatrie: Ein lehrbuch fur studierende und aerzte, 8th edn, vol. 3(2). Leipzig: Barth; 6th edn, 1899.

Kramer, B. A. 1999. Use of ECT in California, revised: 1984–1994. J ECT 15: 245– 51.Google Scholar

Kranz, H. 1955. Das thema des wahns im wandel der zeit. Fortschritte der Neurologie und Psychiatrie 23: 58–72.Google Scholar

Kreye, A. 2005. Hausfrauenreport aus Hollywood. Sueddeutsche Zeitung, April 9, p. 22.

Kroessler, D. 1985. Relative efficacy rates for therapies of delusional depression. Convuls Ther 1: 173–82.Google Scholar

Kuhs, H. 1991. Depressive delusion. Psychopathology 24: 106– 14.Google Scholar

La Rue, A., Spar, J., and Hill, C. D. 1986. Cognitive impairment in late-life depression: Clinical correlates and treatment implications. J Affect Disord 11: 179–84Google Scholar

Lambert, M. V. and Robertson, M. M. 1999. Depression in epilepsy: Etiology, phenomenology, and treatment. Epilepsia 40(Suppl 10): S21–S47.Google Scholar

Lancet, 1940. Editorial: Primum non nocere. Lancet 1: 275.

Lee, P. E., Sykora, K., Gill, S. S., et al. 2005. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: A population-based cohort study in older adults. J Am Geriatr Soc 53: 1374–9.Google Scholar

Lenz, H. 1967. Themenwandel in der psychopathologie. Wiener Zeitschrift für Nervenheilkunde 25: 286–96.Google Scholar

Leonhard, K. 1957. Aufteilung der endogenen Psychosen. Berlin: Akademie-Verlag, pp. 185–217.

Lesser, I. M., Miller, B. L., Boone, K. B., et al. 1991. Brain injury and cognitive function in late-onset psychotic depression. J Neuropsychiatry Clin Neurosci 3: 33–40.Google Scholar

Lesser, I. M., Rubin, R. T., Rifkin, A., et al. 1989. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord 16: 49–58.Google Scholar

Lew, T. Y. and Tollefson, G. 1983. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol Psychiatry 18: 1441–6.Google Scholar

Lewis, A. 1971. “Endogenous” and “exogenous”: A useful dichotomy?Psychol Med 1: 191–6.Google Scholar

Lewis, A. J. 1934. Melancholia: A clinical survey of depressive states. J Ment Sci 80: 277–378.Google Scholar

Lewis, D. A. and Smith, R. E. 1983. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5: 319–32.Google Scholar

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., et al. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 242: 1209–23.Google Scholar

Liu, Z. X. and Wang, D. C. 1992. A clinical and follow-up study in 33 cases of rapid cyclic affective psychosis. Zhonghua Shen Jing Jing Shen Ke Za Zhi 25: 341–3.Google Scholar

Lu, M. L., Pan, J. J., Teng, H. W., et al. 2002. Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother 36: 1387–90.Google Scholar

Lykouras, E., Malliaras, D., Christodoulou, G. N., et al. 1986a. Delusional depression: Phenomenology and response to treatment. Psychopathology 19: 157–64.Google Scholar

Lykouras, E., Malliaras, D., Christodoulou, G. N., et al. 1986b. Delusional depression: Phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 73: 324–9.Google Scholar

Maj, M., Pirozzi, R., and Di Caprio, E. L. 1990. Major depression with mood-congruent psychotic features: A distinct diagnostic entity or a more severe subtype of depression?Acta Psychiatr Scand 82: 439–44.Google Scholar

Malla, A. K., Norman, R. M., Manchanda, R., et al. 2002. One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophr Res 54: 231–42.Google Scholar

Margolese, H. C., Chouinard, G., Beauclair, L., and Belanger, M. C. 2002. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharmacol 22: 347–52.Google Scholar

Markowitz, J., Brown, R., Sweeney, J., and Mann, J. J. 1987. Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatry 144: 1025–9.Google Scholar

Marsh, L., Williams, J. R., Rocco, M., et al. 2004. Psychiatric comorbidities associated with psychosis in patients with Parkinson's disease. Neurology 63: 293–300.Google Scholar

Marshall, M., Lewis, S., Lockwood, A., et al. 2005. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 62: 975–83.Google Scholar

Martin, J. L., Barbanoj, M. J., Schlaepfer, T. E., et al. 2002. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev 2: CD003493.Google Scholar

Mason, B. J., Kocsis, J. H., Frances, A. J., and Mann, J. J. 1990. Amoxapine versus amitriptyline for continuation therapy of depression. J Clin Psychopharmacol 10: 338–43.Google Scholar

Masters, K. M. and Wandless, D. 2005. Use of pulse oximetry during restraint episodes. Psychiatr Serv 56: 1313–14.Google Scholar

Maudsley, H. 1867. The physiology and pathology of mind. New York: Appleton.

Mayberg, H. S., Lozano, A. M., Voon, V., et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–60.Google Scholar

McDonald, C., Bullmore, E., Sham, P., et al. 2005. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder. Br J Psychiatry 18: 369–77.Google Scholar

McGrath, P. I., Stewart, J. W., Nunes, E. N., and Quitkin, F. M. 1994. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant. J Clin Psychiatry 55: 336–9.Google Scholar

McIntyre, R., Mancini, D. A., McCann, S., et al. 2002. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study. Bipolar Disord 4: 207–13.Google Scholar

Meyer, J. H., Kruger, S., Wilson, A. A., et al. 2001. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12: 4121–5.Google Scholar

Meyers, B. S., Klimstra, S. A., Gabriele, M., et al. 2001. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 9: 415–22.Google Scholar

Mingazzini, G. 1926. Die modifikationen der klinischen symptome, die einige psychosen in den letzten jahrzehnten erfahren haben. Psychiatrisch-Neurologische Wochenschrift 28: 68–72.Google Scholar

Mirza, N. R., Bright, J. L., Stanhope, K. J., et al. 2005. Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: A potential role for sodium channels? Psychopharmacol (Berlin) 180: 159–68.Google Scholar

Mueser, K. T., Goodman, L. B., Trumbetta, S. L., et al. 1998. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol 66: 493–9.Google Scholar

Muller-Siecheneder, F., Muller, M. J., Hillert, A., et al. 1998. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 18: 111–20.Google Scholar

Mulsant, B. H., Haskett, R. F., Prudic, J., et al. 1997. Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 154: 559–61.Google Scholar

Mulsant, B. H., Sweet, R. A., Rosen, J., et al. 2001. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 62: 597–604.Google Scholar

Munro, T. A. 1949. On depression. Edinburgh Med J 56: 530–43.Google Scholar

Musa, M. N. and Tripuraneni, B. R. 1993. Lithium-induced polyuria ameliorated by potassium supplementation. Lithium 4: 199–203.Google Scholar

Myers, B. S. and Greenberg, R. 1986. Late-life delusional depression. J Affect Disord 11: 133–7.Google Scholar

Naidu, P. S. and Kulkarni, S. K. 2001. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): Possible involvement of calcium and nitric oxide. Behav Pharmacol 12: 209–16.Google Scholar

Naimark, D., Jackson, E., Rockwell, E., and Jeste, D. V. 1996. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc 44: 296–9.Google Scholar

Navarro, V., Gasto, C., Torres, X., et al. 2001. Citalopram versus nortriptyline in late-life depression: A 12-week randomized single-blind study. Acta Psychiatr Scand 103: 435–40.Google Scholar

Nelson, J. C. and Bowers, M. B. Jr. 1978. Delusional unipolar depression: Description and drug response. Arch Gen Psychiatry 35: 1321–8.Google Scholar

Nelson, J. C. and Charney, D. S. 1981. The symptoms of major depressive illness. Am J Psychiatry 138: 1–13.Google Scholar

Nelson, J. C. and Mazure, C. M. 1986. Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatry 143: 363–6.Google Scholar

Nelson, J. C., Charney, D. S., and Quinlan, D. M. 1981. Evaluation of the DSM-III criteria for melancholia. Arch Gen Psychiatry 38: 555–9.Google Scholar

Nelson, J. C., Price, L. H., Jatlow, P. I. 1986. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression. Am J Psychiatry 143: 1151–4.Google Scholar

Nelson, L. A. and Swartz, C. M. 2000. Melancholic symptoms from concurrent olanzapine and fluoxetine. Ann Clin Psychiatry 12: 167–70.Google Scholar

Niskanen, P. and Achte, K. A. 1972. Disease pictures of depressives psychoses in the decades 1880–89, 1900–09, 1930–39, and 1960–69. Psychiatria Fennica95–100.Google Scholar

Olfson, M., Marcus, S., Sackeim, H. A., Thompson, J., and Pincus, H. A. 1998. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry 155: 2–29.Google Scholar

Overall, J. E., Hollister, L. E., Johnson, M., and Pennington, V. 1966. Nosology of depression and differential response to drugs. JAMA 195: 946–8.Google Scholar

Overall, J. E., Hollister, L. E., Pokorny, A. D., et al. 1962. Drug therapy in depressions: Controlled evaluation of imipramine, isocarboxazide, dextroamphetamine-amobarbital, and placebo. Clin Pharmacol Ther 3: 16–22.Google Scholar

Pai, M., White, A. C., and Deane, A. G. 1986. Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 148: 736–8.Google Scholar

Papakostas, G. I., Alpert, J. E., and Fava, M. 2003. S-adenosyl-methionine in depression: A comprehensive review of the literature. Curr Psychiatry Rep 5: 460–6.Google Scholar

Pare, C. M., Kline, N., Hallstrom, C., and Cooper, T. B. 1982. Will amitriptyline prevent the “cheese” reaction of monoamine oxidase inhibitors? Lancet 2(8291): 183–6.Google Scholar

Parker, G. 2000. Classifying depression: Should paradigms lost be regained? Am J Psychiatry 157: 1195–203.Google Scholar

Parker, G. 2004. Evaluating treatments for the mood disorders: Time for the evidence to get real. Aust NZ J Psychiatry 38: 408–14.Google Scholar

Parker, G., Hadzi-Pavlovic, D., Brodaty, H., et al. 1995. Sub-typing depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med 25: 825–32.Google Scholar

Parker, G., Hadzi-Pavlovic, D., Hickie, I., et al. 1991a. Distinguishing psychotic and non-psychotic melancholia. J Affect Disord 22: 135–48.Google Scholar

Parker, G., Hadzi-Pavlovic, D., Hickie, I., et al. 1991b. Psychotic depression: A review and clinical experience. Aust NZ J Psychiatry 25: 169–80.Google Scholar

Parker, G., Roussos, J., Mitchell, P., et al. 1997. Distinguishing psychotic depression from melancholia. J Affect Disord 42: 155–67.Google Scholar

Parker, G., Roy, K., Hadzi-Pavlovic, D., and Pedic, F. 1992. Psychotic (delusional) depression: A meta-analysis of physical treatments. J Affect Disord 24: 17–24.Google Scholar

Parvin, M. M., Swartz, C. M., and LaMontagne, B. 2004. Patient education by ECT experienced volunteer. J ECT 20: 127–9.Google Scholar

Perry, P. J., Morgan, D. E., Smith, R. E., and Tsuang, M. T. 1982. Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant – antipsychotic combinations. J Affect Disord 4: 195–200.Google Scholar

Petrides, G., Fink, M., Husain, M. M., et al. 2001. ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. J ECT 17: 244–53.Google Scholar

Piasecki, S. D. and Jefferson, J. W. 2004. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry 65: 845–9.Google Scholar

Placidi, G. F., Lenzi, A., Lzzerini, F., et al. 1986. The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 47: 490–4.Google Scholar

Plath, S. 1996. The bell jar (1971), 25th anniversary edn. New York: HarperCollins.

Pollak, P., Tison, F., Rascol, O., et al. 2004. Clozapine in drug induced psychosis in Parkinson's disease: A randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 75: 689–95.Google Scholar

Pope, H. G. and Katz, D. L. 1994. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 51: 375–82.Google Scholar

Popli, A. P., Fuller, M. A., and Jaskiw, G. E. 1997. Sertraline and psychotic symptoms: A case series. Ann Clin Psychiatry 9: 15–17.Google Scholar

Price, J. P. 1978. Chronic depressive illness. BMJ 1: 1200–1.Google Scholar

Price, L. H., Conwell, Y., and Nelson, J. C. 1983. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 140: 318–22.Google Scholar

Prien, R. F., Kupfer, D. J., Mansky, P. A., et al. 1984. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41: 1096–104.Google Scholar

Quitkin, F., Klein, D. F., and Rifkin, A. 1978. Imipramine response in deluded depressive patients. Am J Psychiatry 7: 806–11Google Scholar

Rabheru, K. and Persad, E. 1997. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42: 476–84.Google Scholar

Rabiner, E. A., Bhagwagar, Z., Gunn, R. N., et al. 2001. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am J Psychiatry 158: 2080–2.Google Scholar

Raja, M. and Azzoni, A. 2003. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. Int J Neuropsychopharmacol 6: 409–14.Google Scholar

Ranjan, R. and Meltzer, H. Y. 1996. Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 40: 253–8.Google Scholar

Rapaport, M. H., Judd, L. L., Schettler, P. J., et al. 2002. A descriptive analysis of minor depression. Am J Psychiatry 159: 637–43.Google Scholar

Ries, R. and Bokan, J. 1979. Electroconvulsive therapy following pituitary surgery. J Nerv Ment Dis 167: 767–8.Google Scholar

Robinson, A. D. T. 1988. A century of delusions in south west Scotland. Br J Psychiatry 153: 163–7.Google Scholar

Roose, S. P., Glassman, A. H., Walsh, B. T., et al. 1983. Depression, delusions, and suicide. Am J Psychiatry 140: 1159–62.Google Scholar

Roose, S. P., Sackeim, H. A., Krisnan, K. R. R., et al. 2004. Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial. Am J Psychiatry 161: 2050–9.Google Scholar

Ropacki, S. A. and Jeste, D. V. 2005. Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 162: 2022–30.Google Scholar

Rothschild, A. J. and Duval, S. E. 2003. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry 64: 390–6.Google Scholar

Rothschild, A. J. and Phillips, K. A. 1999. Selective serotonin inhibitors and delusional depression. Am J Psychiatry 156: 977–8.Google Scholar

Rothschild, A. J., Samson, J. A., Bessette, M. P., et al. 1993. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 54: 338–42.Google Scholar

Rothschild, A. J., Williamson, D. J., Tohen, M. F., et al. 2004. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 24: 365–73.Google Scholar

Rush, A. J., Marangell, L. B., Sackeim, H. A., et al. 2005. Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biol Psychiatry 58: 347–54.Google Scholar

Ruskin, D. B. and Goldner, R. 1959. Treatment of depressions in private practice with imipramine. Dis Nerv Syst 20: 391–9.Google Scholar

Sackeim, H. A., Prudic, J., Devanand, D. P., et al. 1993. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–46.Google Scholar

Sanchez-Ramos, J. R., Ortoll, R., and Paulson, G. W. 1996. Visual hallucinations associated with Parkinson disease. Arch Neurol 53: 1265–8.Google Scholar

Sands, J. R. and Harrow, M. 1995. Vulnerability to psychosis in unipolar major depression: Is premorbid functioning involved? Am J Psychiatry 152: 1009–15.Google Scholar

Santora, M. and Carey, B. 2005. Depressed? New York screens for people at risk. New York Times, April 13, p. 1, 16.Google Scholar

Sareen, J., Cox, B. J., Afifi, T. O., et al. 2005. Anxiety disorders and risk for suicidal ideation and suicide attempts. Arch Gen Psychiatry 62: 1249–57.Google Scholar

Schatzberg, A. F. and Rothschild, A. J. 1992. Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 149: 733–45.Google Scholar

Schatzberg, A. F., Posener, J. A., DeBattista, C., et al. 2000. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry 157: 1095–100.Google Scholar

Schildkraut, J. J. 1965. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122: 509–22.Google Scholar

Schmauss, M., Kapfhammer, H. P., Meyr, P., and Hoff, P. 1988. Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 12: 523–32.Google Scholar

Schneider, K. 1920. Die schichtung des emotionalen lebens und der aufbau der depressionszustände. Zeitschrift für die gesamte Neurologie und Psychiatrie 59: 281–6.Google Scholar

Schneider, L. S., Dagerman, K. S., and Insel, P. 2005. Risk of death with atypical antipsychotic drug treatment for dementia. JAMA 294: 1934–43.Google Scholar

Schneider, L. S., Nelson, J. C., Clary, C. M., et al. 2003. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160: 1277–85.Google Scholar

Schneider, P. B. and Villa, J. L. 1961. Essai d'un nouveau médicament antidépressif: Le G 33040 [Opipramol]. Praxis 50: 1378–81.Google Scholar

Schulz, S. C. 1986. The use of low-dose neuroleptics in the treatment of “schizo-obsessive patients.” Am J Psychiatry 143: 1318–19.Google Scholar

Schwartz, A. C., Bradley, R. L., Sexton, M., et al. 2005. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv 56: 212–15.Google Scholar

Seach, J. 2005. How dangerous are volcanoes? http://www.volcanolive.com/eruption3.html, accessed November 4, 2005.

Shepherd, M. 1959. Evaluation of drugs in the treatment of depression. Can Psychiatr Assoc J 4: 120–8.Google Scholar

Shiraishi, H., Koizumi, J., Hori, M., et al. 1992. A computerized tomographic study in patients with delusional and non-delusional depression. Jap J Psychiatry Neurol 46: 99–105.Google Scholar

Shorter, E. 1990. Private clinics in central Europe 1850–1933. Soc Hist Med 3: 159–95.Google Scholar

Shorter, E. 1997. A history of psychiatry from the era of the asylum to the age of Prozac. New York: John Wiley.

Shorter, E. 2005. A historical dictionary of psychiatry. New York: Oxford University Press.

Signer, S. F. and Billings, R. F. 1984. Amoxapine failure – a neuroleptic property? Can J Psychiatry 29: 510–2.Google Scholar

Sigwald, J. and Bouttier, D. 1953. L'utilisation des propriétés neuroplégiques du chlorhydrate chloro-3-(diméthylamino-3'-propyl)-10-phénothiazine en thérapeutique neuro-psychiatrique. Presse Médicale 61: 607–9.Google Scholar

Sigwald, J., Bouttier, D., and Nicolas-Charles, P. 1956. Ambulatory treatment with chlorpromazine. J Clin Exp Psychopathol 17: 57–69.Google Scholar

Simeon, D., Stanley, B., Frances, A., et al. 1992. Self-mutilation in personality disorders: Psychological and biological correlates. Am J Psychiatry 149: 221–6.Google Scholar

Simpson, G. M., El Sheshai, A., Rady, A., et al. 2003. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. J Clin Psychiatry 64: 959–65.Google Scholar

Simpson, S., Baldwin, R. C., Jackson, A., and Burns, A. 1999. The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: Comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features. Biol Psychiatry 45: 193–204.Google Scholar

Sims, J. 1799. Pathological remarks upon various kinds of alienation of mind. Memoirs Med Soc Lond 5: 372–406.Google Scholar

Slater, L. 2005. Who holds the clicker? Mother Jones (magazine), November, 30(6), pp. 62–7, 90, 92.Google Scholar

Solan, W. J., Khan, A., Avery, D. H., and Cohen, S. 1988. Psychotic and nonpsychotic depression: Comparison of response to ECT. J Clin Psychiatry 49: 97–9Google Scholar

Spiker, D. G., Dealy, R. S., Hanin, I., et al. 1986. Treating delusional depressives with amitriptyline. J Clin Psychiatry 47: 243–6.Google Scholar

Spiker, D. G., Stein, J., and Rich, C. L. 1985a. Delusional depression and electroconvulsive therapy: One year later. Convuls Ther 1: 167–72.Google Scholar

Spiker, D. G., Weiss, J. C., Dealy, R. S., et al. 1985b. The pharmacological treatment of delusional depression. Am J Psychiatry 142: 430–6.Google Scholar

Spitzer, R. L., Endicott, J., and Robins, E. 1978. Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35: 773–82.Google Scholar

Spitzer, R. L., Endicott, J., Robins, E., et al. 1975. Preliminary report of the reliability of research diagnostic criteria applied to psychiatric case records. In Dusilovsky, Abraham et al. (eds) Predictability in psychopharmacology: Preclinical and clinical correlations. New York: Raven, pp. 1–47.

Starkstein, S. E., Jorge, R., Mizrahi, R., and Robinson, R. G. 2005. The construct of minor and major depression in Alzheimer's Disease. Am J Psychiatry 162: 2086–93.Google Scholar

Stephens, J. H. and McHugh, P. R. 1991. Characteristics and long-term follow-up of patients hospitalized for mood disorders in the Phipps Clinic, 1913–1940. J Nerv Ment Dis 179: 64–73.Google Scholar

Stevinson, C. and Ernst, E. 2004. Can St. John's wort trigger psychosis? Int J Clin Pharmacol Ther 42: 473–80.Google Scholar

Stoll, A. L., Mayer, P. V., Kolbrener, M., et al. 1994. Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 151: 1642–5.Google Scholar

Strakowski, S. M., Flaum, M., Amador, X., et al. 1996. Racial differences in the diagnosis of psychosis. Schizophrenia Res 21: 117–24.Google Scholar

Stueber, D. and Swartz, C. M. 2006. Carvedilol suppresses intractable hiccups. J Am Board Fam Med 19: 418–21.Google Scholar

Swartz, C. M. 1979. Depression with nonauditory hallucinations: Success with phenelzine. Psychosomatics 20: 286–7.Google Scholar

Swartz, C. M. 1982. Dependency of antidepressant efficacy on thyroid hormone potentiation: Case studies. J Nerv Ment Dis 170: 50–2.Google Scholar

Swartz, C. M. 1984. The justification for ECT. Behav Brain Sci 7: 37.Google Scholar

Swartz, C. M. 1989. Safety and ECT stimulus electrodes: I. Heat liberation at the electrode-to-skin interface. Convuls Ther 5: 171–5.Google Scholar

Swartz, C. M. 1995. Tardive psychopathology. Neuropsychobiology 32: 115–19.Google Scholar

Swartz, C. M. 2000. Physiological response to ECT stimulus dose. Psychiatry Res 97: 229–35.Google Scholar

Swartz, C. M. 2001a. Misdiagnosis of schizophrenia for a patient with epilepsy. Psychiatr Serv 52: 109.Google Scholar

Swartz, C. M. 2001b Olanzapine-lithium encephalopathy. Psychosomatics 42: 370.Google Scholar

Swartz, C. M. 2002. Olanzapine-induced depression. J Pharm Technol 18: 321–3.Google Scholar

Swartz, C. M. 2003a. Antipsychotics as thought simplifiers. Psychiatric Times, January, 20(1), pp. 12–14.Google Scholar

Swartz, C. M. 2003b. Simplicity as a complication: Antipsychotics. Psychiatric Times, February, 20(2): 44–6.Google Scholar

Swartz, C. M. 2003c. Pseudomania. Psychiatric Times, June, 20, pp. 23–5.Google Scholar

Swartz, C. M. 2004a. Antipsychotic psychosis. Psychiatric Times, October, 21 (11), pp. 17–20.Google Scholar

Swartz, C. M. 2004b. Iatrogenic cancer. Psychiatric Times, September, 21(10), pp. 21–4.Google Scholar

Swartz, C. M. 2005. Aspiration and postictal agitation after electroconvulsive therapy with propofol but no succinylcholine or atropinic agent. J ECT 21: 50–1.Google Scholar

Swartz, C. M. and Galang, R. L. 2001. Adverse outcome with delay in catatonia identification in elderly patients. Am J Geriatric Psychiatry 9: 78–80.Google Scholar

Swartz, C. M. and Guadagno, G. 1998. Melancholia with onset during treatment with SSRIs. Ann Clin Psychiatry 10: 177–9.Google Scholar

Swartz, C. M. and Manly, D. T. 2000. Efficiency of the stimulus characteristics of ECT. Am J Psychiatry 157: 1504–6.Google Scholar

Swartz, C. M. and Nelson, A. I. 2005. Rational electroconvulsive therapy electrode placement. Psychiatry 2: 37–43.Google Scholar

Swartz, C. M., Morrow, V., Surles, L., and James, J. F. 2001. Long-term outcome after ECT for catatonic depression. J ECT 17: 180–3.Google Scholar

Sweeney, D., Nelson, C., Bowers, M., et al. 1978. Delusional versus non-delusional depression: Neurochemical differences. Lancet 2: 100–1.Google Scholar

Taylor, M. A., Berenbaum, S. A., Jampala, V. C., and Cloninger, C. R. 1993. Are schizophrenia and affective disorder related? Preliminary data from a family study. Am J Psychiatry 150: 278–85.Google Scholar

Taylor, M. A. and Fink, M. 2006. Melancholia: The diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, UK: Cambridge University Press.

Tsuang, D. and Coryell, W. 1993. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 150: 1182–8.Google Scholar

Tsuang, M. T., Dempsey, M., and Rauscher, F. 1976. A study of atypical schizophrenia. Arch Gen Psychiatry 33: 1157–60.Google Scholar

Tsuang, M. T., Woolson, R. F., and Fleming, J. A. 1979. Long-term outcome of major psychoses. Arch Gen Psychiatry 36: 1295–304.Google Scholar

Tsuang, T., Woolson, R. F., and Fleming, J. A. 1979. Long-term outcome of major psychoses. Arch Gen Psychiatry 36: 1295–304.Google Scholar

Valenstein, E. S. 1987. Great and desperate cures: The rise and decline of psychosurgery and other radical treatments for mental illness. New York: Basic Books.

Broek, N. W., Birkenhager, T. K., Mulder, P. G., et al. 2006. Imipramine is effective in preventing relapse in electro convulsive therapy-responsive depressed inpatients with prior pharmacotheraphy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67: 263–8.Google Scholar

Viguera, A. C., Baldessarini, R. J., Hegarty, J. D., et al. 1997. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54: 49–55.Google Scholar

Orelli, A. 1954. Der Wandel des Inhaltes der depressiven Ideen bei der reinen Melancholie, unter besonderer Berücksichtigung des Inhaltes der Versündigungsideen. Schweizer Archiv für Neurologie und Psychiatrie 73: 217–87.Google Scholar

Vythilingam, M., Chen, J., Bremner, J. D., et al. 2003. Psychotic depression and mortality. Am J Psychiatry 160: 574–6.Google Scholar

Wada, H., Nakajoh, K., Satoh-Nakagawa, T., et al. 2001. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology 47: 271–6.Google Scholar

Walen, S. 2002. It's a funny thing about suicide: A personal experience. Br J Guid Couns 30: 415–30.Google Scholar

Weiss, E., Hummer, M., Koller, D., et al. 2000. Off-label use of antipsychotic drugs. J Clin Psychopharmacol 20: 695–8.Google Scholar

Weissman, M. M., Prusoff, B. A., and Merikangas, K. R. 1984. Is delusional depression related to bipolar disorder? Am J Psychiatry 141: 892–3.Google Scholar

Wernicke, C. 1900. Grundriss der Psychiatrie. Leipzig: Thieme.

Wheatley, D. 1972. Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 26: 229–33.Google Scholar

Whitty, P., Clarke, M., McTigue, O., et al. 2005. Diagnostic stability four years after a first episode of psychosis. Psychiatr Serv 56: 1084–8.Google Scholar

Wilcox, J. A., Ramirez, A. L., and Baida-Fragoso, N. 2000. The prognostic value of thought disorder in psychotic depression. Ann Clin Psychiatry 12: 1–4.Google Scholar

Wolkowitz, O. M., Reus, V. I., Chan, T., et al. 1999. Antiglucocorticoid treatment of depression: Double-blind ketoconazole. Biol Psychiatry 45: 1070–4.Google Scholar

World Health Organization (WHO) 1967. Research in psychopharmacology: Report of a WHO Scientific Group. WHO Technical Report Series No. 371. Geneva: WHO.

Yassa, R., Nastase, C., Dupont, D., and Thibeau, M. 1992. Tardive dyskinesia in elderly psychiatric patients: A 5-year study. Am J Psychiatry 149: 1206–11.Google Scholar

Zanardi, R., Franchini, L., Gasperini, M., et al. 1996. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 153: 1631–3.Google Scholar

Zanardi, R., Franchini, L., Gasperini, M., et al. 1997. Long-term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study. Int Clin Psychopharmacol 12: 195–7.Google Scholar

Zanardi, R., Franchini, L., Gasperini, M., et al. 1998. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: A controlled study. J Clin Psychopharmacol 18: 441–6.Google Scholar

Zanardi, R., Franchini, L., Perez, J., et al. 1999. Dr. Zanardi and colleagues reply. Am J Psychiatry 156: 978.Google Scholar

Zanardi, R., Franchini, L., Serretti, A., et al. 2000. Venlafaxine versus fluvoxamine in the treatment of delusional depression: A pilot double-blind controlled study. J Clin Psychiatry 61: 26–9.Google Scholar

Zimmerman, M. and Spitzer, R. L. 1989. Melancholia: From DSM-III to DSM-III-R. Am J Psychiatry 146: 20–8.Google Scholar

Zimmerman, M., Chelminski, I., and McDermut, W. 2002. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63: 187–93.Google Scholar

Zwanzger, P., Ella, R., Keck, M. E., Rupprecht, R., and Padberg, F. 2002. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 51: 602–3.Google Scholar

Aarsland, D., Larsen, J. P., Cummings, J. L., and Laake, K. 1999. Prevalence and clinical correlates of psychotic symptoms in Parkinson Disease. A community-based study. Arch Neurol 56: 595–601.Google Scholar

Abrams, R. 2002. Electroconvulsive therapy, 4th edn. New York: Oxford University Press.

Abrams, R. and Taylor, M. A. 1983. The importance of mood-incongruent psychotic symptoms in melancholia. J Affect Disord 5: 179–81.Google Scholar

Alexopoulos, G. S., Meyers, B. S., Young, R. C., et al. 1993. The course of geriatric depression with “reversible dementia”: A controlled study. Am J Psychiatry 150: 1693–9.Google Scholar

American Psychiatric Association (APA) 1994. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: APA, pp. 348, 384–6.

Amsterdam, J. D. and Shults, J. 2005. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: A double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 20: 257–64.Google Scholar

Andreassen, O. A., Ferrante, R. J., Aamo, T. O., et al. 2003. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122: 717–25.Google Scholar

Angst, F., Stassen, H. H., Clayton, P. J., and Angst, J. 2002. Mortality of patients with mood disorders: Follow-up over 34–38 years. J Affect Disord 68: 167–81.Google Scholar

Anton, R. F. Jr. and Burch, E. A. Jr. 1990. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 147: 1203–8.Google Scholar

Anton, R. F. Jr. and Burch, E. A. Jr. 1993. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord 28: 125–31.Google Scholar

Aronson, T. A., Shukla, S., and Hoff, A. 1987. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251–9.Google Scholar

Aronson, T. A., Shukla, S., Hoff, A., and Cook, B. 1988. Proposed delusional depression subtypes: Preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69–74Google Scholar

Arroll, B., Macgillivray, S., Ogston, S., et al. 2005. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis. Ann Family Med 3: 449–56.Google Scholar

Associated Press. 2006. Woman not guilty in retrial in the deaths of her 5 children. New York Times, July 27, p. A18.

Avery, D. and Lubrano, A. 1979. Depression treated with imipramine and ECT: The DeCarolis study reconsidered. Am J Psychiatry 136: 559–62.Google Scholar

Avery, D. and Winokur, G. 1976. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029–37.Google Scholar

Bakish, D. 2001. New standard of depression treatment: Remission and full recovery. J Clin Psychiatry 62(Suppl 26): 5–9.Google Scholar

Banken, R. 2002. The use of electroconvulsive therapy in Quebec. Agence d'valuation des technologies et des modes d'intervention en sant (AETMIS). Montreal: AETMIS.

Bassett, S. S. 2005. Cognitive impairment in Parkinson's Disease. Prim Psychiatry 12: 50–55.Google Scholar

Bayley, J. 1881. Case of recurrent melancholia. Lancet 2: 1041–2.Google Scholar

Beck, A. T. 1967. Depression: Clinical, experimental, and theoretical aspects. New York: Harper & Row.

Belanoff, J. K., Rothschild, A. J., Cassidy, F., et al. 2002. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386–92.Google Scholar

Bellini, L., Gatti, F., Gasperini, M., and Smeraldi, E. 1992. A comparison between delusional and non-delusional depressives. J Affect Disord 25: 129–38.Google Scholar

Benziger, B. F. 1969. The prison of my mind. New York: Walker.

Bergemann, N., Frick, A., Parzer, P., and Kopitz, J. 2004. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. Pharmacopsychiatry 37: 63–8.Google Scholar

Birkenhager, T. K. and Moleman, P. 1999. Two new antidepressants: Mirtazapine and venlafaxine. Ned Tijdscr Geneeskd 143: 934–7.Google Scholar

Birkenhager, T. K., Pluijms, E. M., and Lucius, S. A. 2003. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord 74: 191–5.Google Scholar

Black, D. W. and Winokur, G. 1989. Psychotic and nonpsychotic depression: Comparison of response to ECT. J Clin Psychiatry 50: 186.Google Scholar

Bonomo, V. and Fogliani, A. M. 2000. Citalopram and haloperidol for psychotic depression. Am J Psychiatry 157: 1706–7.Google Scholar

Bowers, M. B. and Swigar, M. E. 1988. Psychotic patients who become worse on neuroleptics. J Clin Psychopharmacol 8: 417–21.Google Scholar

Bremner, J. D., Vythinlingam, M., Ng, C. K., et al. 2003. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 289: 3125–34.Google Scholar

Breslau, N. and Meltzer, H. Y. 1988. Validity of subtyping psychotic depression: Examination of phenomenology and demographic characteristics. Am J Psychiatry 145: 35–40.Google Scholar

Brockington, I. F., Roper, A., Copas, J., et al. 1991. Schizophrenia, bipolar disorder and depression. A discriminant analysis, using “lifetime” psychopathology ratings. Br J Psychiatry 159: 485–94.Google Scholar

Brown, G. W., Ni Bhrolchain, M., and Harris, T. O. 1979. Psychotic and neurotic depression. Part 3. Aetiological and background factors. J Affect Disord 1: 195–211.Google Scholar

Brown, R. P., Frances, A., Kocsis, J. H., and Mann, J. J. 1982. Psychotic vs. nonpsychotic depression: Comparison of treatment response. J Nerv Ment Dis 170: 635–7Google Scholar

Brown, T. A., Campbell, L. A., Lehman, C. L., et al. 2001. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 110: 585–99.Google Scholar

Brujin, J. A., Moleman, P., Mulder, P. G., et al. 1996. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacol (Berlin) 237: 231–7.Google Scholar

Burch, E. A. and Goldschmidt, T. J. 1983. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. South Med J 76: 991–5.Google Scholar

Cade, J. F. J. 1949. Lithium salts in the treatment of psychotic excitement. Med J Aust 2: 349–52.Google Scholar

Calabrese, J. R., Keck, P. B., MacFadden, W., et al. 2005. A randomized double-blind placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162: 1351–60.Google Scholar

Carpenter, W. T. and Buchanan, R. W. 1994. Schizophrenia. N Engl J Med 330: 681–90.Google Scholar

Carroll, B. J. 1981. Review of Harold I. Kaplan, et al. (eds) Comprehensive textbook of psychiatry, 3rd edn. Am J Psychiatry 138: 705–7.

Carroll, B. J. 1982. The dexamethasone suppression test for melancholia. Br J Psychiatry 140: 292–304.Google Scholar

Carroll, B. J. 1983. Neurobiologic dimensions of depression and mania. In Jules Angst (ed.) The origins of depression: Current concepts and approaches. Berlin: Springer.

Carroll, B. J., Curtis, G. C., and Mendels, J. 1976. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6: 235–44.Google Scholar

Carroll, B. T., Thomas, C., Jayanti, K., et al. 2005. Treating persistent catatonia when benzodiazepines fail. Curr Psychiatry 4: 56–64.Google Scholar

Casey, D. A. 1987. Electroconvulsive therapy in the neuroleptic malignant syndrome. Convuls Ther 3: 278–83.Google Scholar

Cerletti, U. 1940. L'Elettroshock. Rivista Sperimentale di Freniatria 64: 209–310.Google Scholar

Chan, C. H., Janicak, P. G., Davis, J. M., et al. 1987. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 48: 197–200.Google Scholar

Chelminski, I., Zimmerman, M., and Mattia, J. I. 2000. Diagnosing melancholia. J Clin Psychiatry 61: 874–5.Google Scholar

Chouinard, G. and Steinberg, S. 1984. New clinical concepts on neuroleptic-induced supersensitivity disorders: Tardive dyskinesia and supersensitivity psychosis. In Stancer, H. C., Garfinkel, P. E., and Rakoff, V. M. (eds) Guidelines for the use of psychotropic drugs. New York: Spectrum, pp. 205–27.

Corcept Therapeutics, Inc. 2006. Corcept Therapeutics announces negative results from the first of three phase 3 studies evaluating CORLUX(R) for treating the psychotic features of psychotic major depression. PR Newswire, August 25, accessed September 13, 2006 at http://biz.yahoo.com/prnews/060825/laf018.html?.v=61

Cotard, J. 1880. Du délire des négations. Archives de neurologie 4: 152–70.Google Scholar

Coryell, W. and Tsuang, M. T. 1982. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry 39: 1181–4.Google Scholar

Coryell, W., Pfohl, B., and Zimmerman, M. 1984. The clinical and neuroendocrine features of pscyhotic depression. J Nerv Ment Dis 172: 521–8.Google Scholar

Coryell, W., Zimmerman, M., and Pfohl, B. 1986. Outcome at discharge and six months in major depression. The significance of psychotic features. J Nerv Ment Dis 174: 92–6Google Scholar

Cullen, M., Mitchell, P., Brodaty, H., et al. 1991. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 52: 472–6.Google Scholar

Davidson, J., McLeod, M., Law-Yone, B., and Linnoila, M. 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–42.Google Scholar

DeBattista, C., Belanoff, J., Glass, S., et al. 2006. Mifeprisone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 60: 1343–9.Google Scholar

Montigny, C., Grunberg, F., Mayer, A., et al. 1981. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–6.Google Scholar

DelBello, M. P., Carlson, G. A., Tohen, M., et al. 2003. Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. J Child Adolesc Psychopharmacol 13: 173–85.Google Scholar

Denber, H. C. B. 1957. Treatment of chlorpromazine-diethazine in depression. Dis Nerv Syst 17: 76–9.Google Scholar

Denno, D. W. 2003. Who is Andrea Yates? A short story about insanity. Duke J Gend Law Policy 10: 1–139.Google Scholar

Dietrich, D. E., Godecke-Koch, T., Richter-Witte, C., and Emrich, H. M. 2004. Lamotrigine in the treatment of confusion psychosis, a case report. Pharmacopsychiatry 37: 88–90.Google Scholar

Donlon, P. T., Biertuemphel, H., and Willenbring, M. 1981. Amoxapine and amitriptyline in the outpatient treatment of endogenous depression. J Clin Psychiatry 42: 11–15.Google Scholar

Downs, J. M., Akiskal, H. G., and Rosenthal, T. L. 1993. Neuroleptic-induced pseudoschizoaffective disorder (abstract 146). Proc Am Psychiatric Assoc Annual Meet, p. 153 (full program on audiotape).Google Scholar

Dubovsky, S. L. and Thomas, M. 1992. Psychotic depression: Advances in conceptualization and treatment. Hosp Comm Psychiatry 43: 1189–98.Google Scholar

Eagles, J. M. 1983. Delusional depressive in-patients, 1892–1982. Br J Psychiatry 143: 558–63.Google Scholar

Erfurth, A., Walden, J., and Grunze, H. 1998. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38: 204–5.Google Scholar

Ernst, K. 1983. Geisteskrankheit ohne institution: eine feldstudie im Kanton Fribourg aus dem jahr 1875. Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie 133: 239–62.Google Scholar

Evans, D. L. and Nemeroff, C. B. 1987. The clinical use of the Dexamethasone Suppression Test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatr Res 21: 185–94.Google Scholar

Feighner, J. P., Robins, E., Guze, S. B., et al. 1972. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63.Google Scholar

Fenichel, O. 1945. The psychoanalytic theory of neurosis. New York: Norton.

Fink, M. 1979. A theory of convulsive therapy (chapter 14). In M. Fink (ed.) Convulsive therapy: Theory and practice. New York: Raven Press, p. 173.

Fink, M. and Taylor, M. A. 2003. Catatonia: A clinician's guide to diagnosis and treatment. New York: Cambridge University Press.

Fink, M., Klein, D. F., and Kramer, J. C. 1965. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Psychopharmacologia 7: 27–36.Google Scholar

Finlay-Jones, R. and Parker, G. 1993. A consensus conference on psychotic depression. Aust NZ J Psychiatry 27: 581–9.Google Scholar

Fish, F. 1964. Concluding observations. In E. Beresford Davies (ed.) Depression: Proceedings of the symposium held at Cambridge 22 to 26 September 1959. Cambridge, UK: Cambridge University Press, pp. 349–52.

Flint, A. J. and Rifat, S. L. 1998a. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–8.Google Scholar

Flint, A. J. and Rifat, S. L. 1998b. Two-year outcome of psychotic depression in late life. Am J Psychiatry 155: 178–83.Google Scholar

Flor-Henry, P. 1983. Determinants of psychosis in epilepsy, laterality and forced normalization. Biol Psychiatry 18: 1045–57.Google Scholar

Freud, S. 1946. Trauer und melancholie (1916). In Freud, (ed.) Gesammelte Werke, vol. 10. Frankfurt: M. Fischer, pp. 428–46.

Freyhan, F. A. 1959. Clinical effectiveness of tofranil in the treatment of depressive psychoses. Can Psychiatr Assoc J 4(Suppl): S86–S97.Google Scholar

Freyhan, F. A. 1961. The influence of specific and non-specific factors on the clinical effects of psychotropic drugs. Neuropsychopharmacology 2: 189–203.Google Scholar